chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Right arm hurt after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Right arm hurt after 1st dose) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 025A21A0) for COVID-19 vaccination.     The patient's past medical history included Breast cancer. Previously administered products included for Shingles: Shingrix (The patient completed the vaccination series 3 years ago). Concurrent medical conditions included Heart failure, Lupus syndrome, Shingles and Vision loss (Lost vision in one eye).   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced PAIN IN EXTREMITY (Right arm hurt after 1st dose). On 07-Feb-2021, PAIN IN EXTREMITY (Right arm hurt after 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient takes unspecified concomitant medications for autoimmune conditions and mild pain. No treatment medication use was provided by the reporter.   This case was linked to MOD-2021-228310 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient hasn't received 2nd dose yet; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient hasn't received 2nd dose yet) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient hasn't received 2nd dose yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient hasn't received 2nd dose yet) outcome was unknown.            No concomitant medication was reported. Treatment medication was not provided.   Reporter did not allow further contact
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Cough, Headache, Hypertension
Clinical narrative: Coughing; Sharp pains in the right side of the head; Blood pressure high; This spontaneous case was reported by a nurse and describes the occurrence of HYPERTENSION (Blood pressure high), COUGH (Coughing) and HEADACHE (Sharp pains in the right side of the head) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic bronchitis.    On 03-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jun-2021, the patient experienced HYPERTENSION (Blood pressure high). On an unknown date, the patient experienced COUGH (Coughing) and HEADACHE (Sharp pains in the right side of the head). At the time of the report, HYPERTENSION (Blood pressure high), COUGH (Coughing) and HEADACHE (Sharp pains in the right side of the head) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jun-2021, Blood pressure measurement: then it went down (Low) Low and 280/90 (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. The patient did not take any treatment medications for the symptoms. The patient experienced sharp pain which was like a stab. The patient went to emergency room (ER) on 12 Jun 2021, and studies were conducted. The patient's blood samples were collected and everything showed normal. The patient mentioned that the cough was more now and more frequent, specially at night.
Sex: U
Vaccine: COVID19
Symptoms: Aphonia, Chest discomfort, Headache, Pyrexia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of chest discomfort (chest tightness), aphonia (losing my voice), headache and pyrexia (fever) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced chest discomfort (chest tightness), aphonia (losing my voice), headache and pyrexia (fever). At the time of the report, chest discomfort (chest tightness), aphonia (losing my voice), headache and pyrexia (fever) outcome: unknown. Concomitant medication and treatment information not provided.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Inappropriate schedule of product administration, Lymph node pain, Night sweats
Clinical narrative: Sweats; Night sweats; Something in lymph nodes; 57 days between first and second dose; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweats), NIGHT SWEATS (Night sweats), LYMPH NODE PAIN (Something in lymph nodes) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (57 days between first and second dose) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 029A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included VALPROATE SEMISODIUM (DEPAKOTE), METFORMIN and GLIPIZIDE for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (57 days between first and second dose). On an unknown date, the patient experienced HYPERHIDROSIS (Sweats), NIGHT SWEATS (Night sweats) and LYMPH NODE PAIN (Something in lymph nodes). At the time of the report, HYPERHIDROSIS (Sweats), NIGHT SWEATS (Night sweats), LYMPH NODE PAIN (Something in lymph nodes) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (57 days between first and second dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication included unspecified antibiotics and pain medication.  Patient received both doses of Moderna COVID Vaccine, first dose on 3Mar2021 and second dose on 29Apr2021. First dose was administered on left non-dominant arm and second dose on right dominant arm. Patient said of being a little worried and alarmed. Patient went to see doctor last week because has something in lymph nodes.   Patient also had sweats and night sweats and these symptoms started approximately a week and a half ago.   Concomitant medication included Avipiline, lazole and medications for psychiatric disorders, blood pressure and diabetes.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rash, Rash pruritic, Somnolence
Clinical narrative: Painful; Itchy rash; Hard at night; Bad rash on her back/ Bad rash on her stomach/ Bad rash up to her neck; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Painful), RASH PRURITIC (Itchy rash), SOMNOLENCE (Hard at night) and RASH (Bad rash on her back/ Bad rash on her stomach/ Bad rash up to her neck) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O35C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 15-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-May-2021, the patient experienced PAIN (Painful), RASH PRURITIC (Itchy rash), SOMNOLENCE (Hard at night) and RASH (Bad rash on her back/ Bad rash on her stomach/ Bad rash up to her neck). At the time of the report, PAIN (Painful), RASH PRURITIC (Itchy rash), SOMNOLENCE (Hard at night) and RASH (Bad rash on her back/ Bad rash on her stomach/ Bad rash up to her neck) outcome was unknown.            Concomitant medications included vitamins (unspecified).  No treatment medications was provided by the reporter.   This case was linked to MOD-2021-228459 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Mobility decreased, Muscular weakness, Myalgia
Clinical narrative: Bilateral arms ache; Ache from low back to back of both thighs, to the knees; Ache from low back to back of both thighs, to the knees; Muscles are weak; Hard time going up or down the stairs; Ache from low back to back of both thighs, to the knees; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Ache from low back to back of both thighs, to the knees), MUSCULAR WEAKNESS (Muscles are weak), MOBILITY DECREASED (Hard time going up or down the stairs), PAIN IN EXTREMITY (Ache from low back to back of both thighs, to the knees) and MYALGIA (Bilateral arms ache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced BACK PAIN (Ache from low back to back of both thighs, to the knees), MUSCULAR WEAKNESS (Muscles are weak), MOBILITY DECREASED (Hard time going up or down the stairs), PAIN IN EXTREMITY (Ache from low back to back of both thighs, to the knees) and ARTHRALGIA (Ache from low back to back of both thighs, to the knees). On an unknown date, the patient experienced MYALGIA (Bilateral arms ache). At the time of the report, BACK PAIN (Ache from low back to back of both thighs, to the knees), MUSCULAR WEAKNESS (Muscles are weak), MOBILITY DECREASED (Hard time going up or down the stairs), PAIN IN EXTREMITY (Ache from low back to back of both thighs, to the knees), MYALGIA (Bilateral arms ache) and ARTHRALGIA (Ache from low back to back of both thighs, to the knees) outcome was unknown.            No concomitant medications reported.  After 3 months, the symptoms are not better, and now the patient also had bilateral achy arms. The patient had visited her HCP once about this and was given an order for physical therapy.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Bilateral arms ache; Ache from low back to back of both thighs, to the knees; Ache from low back to back of both thighs, to the knees; Muscles are weak; Hard time going up or down the stairs; Ache from low back to back of both thighs, to the knees; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Ache from low back to back of both thighs, to the knees), MUSCULAR WEAKNESS (Muscles are weak), MOBILITY DECREASED (Hard time going up or down the stairs), PAIN IN EXTREMITY (Ache from low back to back of both thighs, to the knees) and MYALGIA (Bilateral arms ache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced BACK PAIN (Ache from low back to back of both thighs, to the knees), MUSCULAR WEAKNESS (Muscles are weak), MOBILITY DECREASED (Hard time going up or down the stairs), PAIN IN EXTREMITY (Ache from low back to back of both thighs, to the knees) and ARTHRALGIA (Ache from low back to back of both thighs, to the knees). On an unknown date, the patient experienced MYALGIA (Bilateral arms ache). At the time of the report, BACK PAIN (Ache from low back to back of both thighs, to the knees), MUSCULAR WEAKNESS (Muscles are weak), MOBILITY DECREASED (Hard time going up or down the stairs), PAIN IN EXTREMITY (Ache from low back to back of both thighs, to the knees), MYALGIA (Bilateral arms ache) and ARTHRALGIA (Ache from low back to back of both thighs, to the knees) outcome was unknown.            No concomitant medications reported.  After 3 months, the symptoms are not better, and now the patient also had bilateral achy arms. The patient had visited her HCP once about this and was given an order for physical therapy.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Wrong product administered
Clinical narrative: Pfizer given accidentally as second dose.; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Pfizer given accidentally as second dose.) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jun-2021, the patient started TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 19-Jun-2021, the patient experienced WRONG PRODUCT ADMINISTERED (Pfizer given accidentally as second dose.). On 19-Jun-2021, WRONG PRODUCT ADMINISTERED (Pfizer given accidentally as second dose.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medications were not reported.  The treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Soreness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Soreness). At the time of the report, MYALGIA (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission in error, SARS-CoV-2 test
Clinical narrative: Missed 2nd dose of M; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION IN ERROR (Missed 2nd dose of M) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION IN ERROR (Missed 2nd dose of M). At the time of the report, PRODUCT DOSE OMISSION IN ERROR (Missed 2nd dose of M) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: My first vaccine was in April is it too late to get the second shot now?; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (My first vaccine was in April is it too late to get the second shot now?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (My first vaccine was in April is it too late to get the second shot now?). At the time of the report, PRODUCT DOSE OMISSION ISSUE (My first vaccine was in April is it too late to get the second shot now?) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications were not reported. The treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: I feel really tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (I feel really tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (I feel really tired). At the time of the report, FATIGUE (I feel really tired) had not resolved.            Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Body temperature, Dyspnoea, Headache, Myalgia
Clinical narrative: Panic Attack; Short of Breath; Headache; Sore Injection Site; Hard to the touch Injected Muscle; Temperature 99.3F; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PANIC ATTACK (Panic Attack), DYSPNOEA (Short of Breath), HEADACHE (Headache), VACCINATION SITE PAIN (Sore Injection Site) and MYALGIA (Hard to the touch Injected Muscle) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Jun-2021, the patient experienced PANIC ATTACK (Panic Attack), DYSPNOEA (Short of Breath), HEADACHE (Headache), VACCINATION SITE PAIN (Sore Injection Site), MYALGIA (Hard to the touch Injected Muscle), PYREXIA (Temperature 99.3F) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) for Headache, at a dose of 1 dosage form. At the time of the report, PANIC ATTACK (Panic Attack), DYSPNOEA (Short of Breath), HEADACHE (Headache), VACCINATION SITE PAIN (Sore Injection Site), MYALGIA (Hard to the touch Injected Muscle), PYREXIA (Temperature 99.3F) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jun-2021, Blood pressure measurement: 180 mmHg (High) High systolic pressure.. On 18-Jun-2021, Body temperature: 99.3 farenheit (High) Slightly increased.         The action taken with mRNA-1273 in response to the event is not applicable.  It is reported that the patient had went to emergency room and the health professionals have planned to test the patient for COVID-19.   This case was linked to MOD-2021-186788 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Panic attack, Pyrexia, Vaccination site pain
Clinical narrative: Panic Attack; Short of Breath; Headache; Sore Injection Site; Hard to the touch Injected Muscle; Temperature 99.3F; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PANIC ATTACK (Panic Attack), DYSPNOEA (Short of Breath), HEADACHE (Headache), VACCINATION SITE PAIN (Sore Injection Site) and MYALGIA (Hard to the touch Injected Muscle) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Jun-2021, the patient experienced PANIC ATTACK (Panic Attack), DYSPNOEA (Short of Breath), HEADACHE (Headache), VACCINATION SITE PAIN (Sore Injection Site), MYALGIA (Hard to the touch Injected Muscle), PYREXIA (Temperature 99.3F) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) for Headache, at a dose of 1 dosage form. At the time of the report, PANIC ATTACK (Panic Attack), DYSPNOEA (Short of Breath), HEADACHE (Headache), VACCINATION SITE PAIN (Sore Injection Site), MYALGIA (Hard to the touch Injected Muscle), PYREXIA (Temperature 99.3F) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jun-2021, Blood pressure measurement: 180 mmHg (High) High systolic pressure.. On 18-Jun-2021, Body temperature: 99.3 farenheit (High) Slightly increased.         The action taken with mRNA-1273 in response to the event is not applicable.  It is reported that the patient had went to emergency room and the health professionals have planned to test the patient for COVID-19.   This case was linked to MOD-2021-186788 (Patient Link).
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: developed headache 3 weeks later of the second shot; developed fever 3 weeks later of the second shot; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (developed headache 3 weeks later of the second shot) and PYREXIA (developed fever 3 weeks later of the second shot) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jun-2021, the patient experienced HEADACHE (developed headache 3 weeks later of the second shot) and PYREXIA (developed fever 3 weeks later of the second shot). At the time of the report, HEADACHE (developed headache 3 weeks later of the second shot) and PYREXIA (developed fever 3 weeks later of the second shot) outcome was unknown.            No concomitant medication was reported.  Treatment medication was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Acne
Clinical narrative: acne; This spontaneous case was reported by a consumer and describes the occurrence of ACNE (acne) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACNE (acne). At the time of the report, ACNE (acne) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Sore arm after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore arm after 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Sore arm after 2nd dose). At the time of the report, MYALGIA (Sore arm after 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Body temperature, Headache, Nausea
Clinical narrative: Backache; Fever of 100.4; Headache; Joint pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Backache), PYREXIA (Fever of 100.4), HEADACHE (Headache), ARTHRALGIA (Joint pain) and NAUSEA (Nausea) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The medical history was not provided by the reporter.  Concurrent medical conditions included Blood pressure. Concomitant products included LISINOPRIL and METOPROLOL SUCCINATE for an unknown indication.   On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Jun-2021, the patient experienced BACK PAIN (Backache), PYREXIA (Fever of 100.4), HEADACHE (Headache), ARTHRALGIA (Joint pain) and NAUSEA (Nausea). The patient was treated with ACETAMINOPHEN on 17-Jun-2021 at a dose of 1 UNK. At the time of the report, BACK PAIN (Backache), PYREXIA (Fever of 100.4), HEADACHE (Headache) and ARTHRALGIA (Joint pain) outcome was unknown and NAUSEA (Nausea) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jun-2021, Body temperature: 100.4 (High) High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not applicable.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Backache; Fever of 100.4; Headache; Joint pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Backache), PYREXIA (Fever of 100.4), HEADACHE (Headache), ARTHRALGIA (Joint pain) and NAUSEA (Nausea) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The medical history was not provided by the reporter.  Concurrent medical conditions included Blood pressure. Concomitant products included LISINOPRIL and METOPROLOL SUCCINATE for an unknown indication.   On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Jun-2021, the patient experienced BACK PAIN (Backache), PYREXIA (Fever of 100.4), HEADACHE (Headache), ARTHRALGIA (Joint pain) and NAUSEA (Nausea). The patient was treated with ACETAMINOPHEN on 17-Jun-2021 at a dose of 1 UNK. At the time of the report, BACK PAIN (Backache), PYREXIA (Fever of 100.4), HEADACHE (Headache) and ARTHRALGIA (Joint pain) outcome was unknown and NAUSEA (Nausea) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jun-2021, Body temperature: 100.4 (High) High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Rash, Skin warm
Clinical narrative: it's a bit warm; rash; This spontaneous case was reported by a consumer and describes the occurrence of SKIN WARM (it's a bit warm) and RASH (rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) UNK dosage form. On an unknown date, the patient experienced SKIN WARM (it's a bit warm) and RASH (rash). At the time of the report, SKIN WARM (it's a bit warm) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided by the reporter. No Treatment medications were provided by the reporter.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed
Clinical narrative: Is not getting her menstrual cycle; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION DELAYED (Is not getting her menstrual cycle) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]), VITAMINS NOS and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENSTRUATION DELAYED (Is not getting her menstrual cycle). At the time of the report, MENSTRUATION DELAYED (Is not getting her menstrual cycle) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication also included OTC Heartburn medication and Anti Anxiety medication. Patient stated that her menstrual cycle was pretty regular normally. No treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Dysstasia
Clinical narrative: "two other patients couldn't even stand"; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DYSSTASIA ("two other patients couldn't even stand") in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSSTASIA ("two other patients couldn't even stand"). At the time of the report, DYSSTASIA ("two other patients couldn't even stand") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint stiffness, Mobility decreased, Pain, Rhinorrhoea
Clinical narrative: Hard a hard time sitting in a chair and using the bathroom/ Can't lift her arms; Stuffy, runny nose; Severe stiffness in her elbows and knees; Did not experience pain like this before; Pain in the joints everywhere in her body/Side pain and wrist pain last week; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Hard a hard time sitting in a chair and using the bathroom/ Can't lift her arms), RHINORRHOEA (Stuffy, runny nose), JOINT STIFFNESS (Severe stiffness in her elbows and knees), PAIN (Did not experience pain like this before) and ARTHRALGIA (Pain in the joints everywhere in her body/Side pain and wrist pain last week) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (Hard a hard time sitting in a chair and using the bathroom/ Can't lift her arms), RHINORRHOEA (Stuffy, runny nose), JOINT STIFFNESS (Severe stiffness in her elbows and knees), PAIN (Did not experience pain like this before) and ARTHRALGIA (Pain in the joints everywhere in her body/Side pain and wrist pain last week). At the time of the report, MOBILITY DECREASED (Hard a hard time sitting in a chair and using the bathroom/ Can't lift her arms), RHINORRHOEA (Stuffy, runny nose), JOINT STIFFNESS (Severe stiffness in her elbows and knees), PAIN (Did not experience pain like this before) and ARTHRALGIA (Pain in the joints everywhere in her body/Side pain and wrist pain last week) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was reported by reporter.   This case was linked to MOD-2021-228387 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: follow-up was received and contains no significant information
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dysstasia, Influenza, Myalgia
Clinical narrative: she is struggling to get up; she feels like she has the flu.; body aches, her whole body hurts, pain; This spontaneous case was reported by a patient and describes the occurrence of DYSSTASIA (she is struggling to get up), INFLUENZA (she feels like she has the flu.) and MYALGIA (body aches, her whole body hurts, pain) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]), VITAMINS NOS and VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 17-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jun-2021, the patient experienced DYSSTASIA (she is struggling to get up), INFLUENZA (she feels like she has the flu.) and MYALGIA (body aches, her whole body hurts, pain). At the time of the report, DYSSTASIA (she is struggling to get up), INFLUENZA (she feels like she has the flu.) and MYALGIA (body aches, her whole body hurts, pain) outcome was unknown.            Concomitant medication  unspecified  OTC Heartburn medication and unspecified Anti Anxiety medication.  Treatment information were not Advil provided.
Age: 81.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: I had an adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I had an adverse reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (I had an adverse reaction). At the time of the report, VACCINATION COMPLICATION (I had an adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Sex: U
Vaccine: COVID19
Symptoms: Transplant
Clinical narrative: Patient had a transplant after getting both doses; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of TRANSPLANT (Patient had a transplant after getting both doses) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TRANSPLANT (Patient had a transplant after getting both doses). At the time of the report, TRANSPLANT (Patient had a transplant after getting both doses) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered TRANSPLANT (Patient had a transplant after getting both doses) to be not related.    The patient recently underwent a transplant and the doctor was recommending that the patient get a 3rd dose because the antirejection medication might have rejected the vaccine. The pharmacist confirmed that the transplant was not related to any possible side effects the patient might have had after getting the Moderna COVID-19 vaccine.
Sex: U
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Dull pain in left thight and hand.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Dull pain in left thight and hand.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Dull pain in left thight and hand.). At the time of the report, PAIN (Dull pain in left thight and hand.) outcome was unknown.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhoea; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhoea) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhoea). At the time of the report, DIARRHOEA (Diarrhoea) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: Myalgia; Feeling a little tired; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Myalgia) and FATIGUE (Feeling a little tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jun-2021, the patient experienced MYALGIA (Myalgia) and FATIGUE (Feeling a little tired). At the time of the report, MYALGIA (Myalgia) and FATIGUE (Feeling a little tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications were not reported.  The treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: i experienced a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (i experienced a sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (i experienced a sore arm). At the time of the report, MYALGIA (i experienced a sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: experiencing a rash on my shins; This spontaneous case was reported by a consumer and describes the occurrence of RASH (experiencing a rash on my shins) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) unknown. On an unknown date, the patient experienced RASH (experiencing a rash on my shins). At the time of the report, RASH (experiencing a rash on my shins) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided. No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Fallow up received and contains no new information.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: sore arm; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) and PAIN IN EXTREMITY (pain in arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE and OLMESARTAN for Blood pressure management.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced MYALGIA (sore arm) and PAIN IN EXTREMITY (pain in arm). On 02-Feb-2021, MYALGIA (sore arm) and PAIN IN EXTREMITY (pain in arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Mexican yan harmone supplement pills were taken as concomitant medication along with others, as specified by the reporter. Treatment with Advil was taken pertained to the symptoms experienced.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint stiffness, Mobility decreased, Pain, Rhinorrhoea
Clinical narrative: Stiffness joints; Mobility decreased; runny nose; pain; wrist pain; This spontaneous case was reported by a consumer and describes the occurrence of JOINT STIFFNESS (Stiffness joints), MOBILITY DECREASED (Mobility decreased), RHINORRHOEA (runny nose), PAIN (pain) and ARTHRALGIA (wrist pain) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 003A21!,) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced JOINT STIFFNESS (Stiffness joints), MOBILITY DECREASED (Mobility decreased), RHINORRHOEA (runny nose), PAIN (pain) and ARTHRALGIA (wrist pain). At the time of the report, JOINT STIFFNESS (Stiffness joints), MOBILITY DECREASED (Mobility decreased), RHINORRHOEA (runny nose), PAIN (pain) and ARTHRALGIA (wrist pain) had resolved.            No treatment medications were reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up received on 28-Jul-2021 and contains no new information.
Sex: U
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: swollen arm after second shot; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm after second shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen arm after second shot). At the time of the report, PERIPHERAL SWELLING (swollen arm after second shot) outcome was unknown.            No concomitant medications were reported. No treatment medication was reported.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dysstasia, Fear, Gait inability, Neuralgia, Pain in extremity
Clinical narrative: couldn't walk for two days; All I could do was stand and that was hard; It felt like nerve pain; Was so frightened; pain in legs/"the pain was down my legs"/"the pain was ridiculous"; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in legs/"the pain was down my legs"/"the pain was ridiculous"), GAIT INABILITY (couldn't walk for two days), DYSSTASIA (All I could do was stand and that was hard), NEURALGIA (It felt like nerve pain) and FEAR (Was so frightened) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE and OLMESARTAN for Blood pressure management.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Jan-2021, the patient experienced PAIN IN EXTREMITY (pain in legs/"the pain was down my legs"/"the pain was ridiculous"). On 28-Feb-2021, the patient experienced GAIT INABILITY (couldn't walk for two days), DYSSTASIA (All I could do was stand and that was hard), NEURALGIA (It felt like nerve pain) and FEAR (Was so frightened). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 02-Feb-2021, PAIN IN EXTREMITY (pain in legs/"the pain was down my legs"/"the pain was ridiculous") had resolved. On 02-Mar-2021, GAIT INABILITY (couldn't walk for two days), DYSSTASIA (All I could do was stand and that was hard), NEURALGIA (It felt like nerve pain) and FEAR (Was so frightened) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products included Mexican yam hormone supplement pills The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.